Shimoni, Avichai <br/><br/>
A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.  [electronic resource] 

 -  Cancer  Oct 2012 
 - 4706-14 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.27418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carmustine--administration & dosage<br/>Cytarabine--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Early Termination of Clinical Trials<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Odds Ratio<br/>Prognosis<br/>Proportional Hazards Models<br/>Recurrence<br/>Risk Factors<br/>Sample Size<br/>Stem Cell Transplantation<br/>Survival Analysis<br/>Transplantation Conditioning--methods<br/>Transplantation, Autologous<br/>Treatment Outcome